{"id":355254,"date":"2020-10-27T23:17:32","date_gmt":"2020-10-28T06:17:32","guid":{"rendered":"https:\/\/nai500.com\/blog\/2020\/10\/cytodyn-to-file-marketing-application-for-leronlimab-takeda-submits-supplemental-application-for-cabometyx\/"},"modified":"2020-10-27T23:18:22","modified_gmt":"2020-10-28T06:18:22","slug":"%e5%8c%bb%e7%96%97%e4%bf%9d%e5%81%a5%e7%b2%be%e9%80%89-cytodyn-%e6%8f%90%e4%ba%a4-leronlimab-%e7%9a%84%e8%90%a5%e9%94%80%e7%94%b3%e8%af%b7%e6%ad%a6%e7%94%b0%e6%8f%90%e4%ba%a4-cabometyx-%e7%9a%84","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hans\/blog\/2020\/10\/%e5%8c%bb%e7%96%97%e4%bf%9d%e5%81%a5%e7%b2%be%e9%80%89-cytodyn-%e6%8f%90%e4%ba%a4-leronlimab-%e7%9a%84%e8%90%a5%e9%94%80%e7%94%b3%e8%af%b7%e6%ad%a6%e7%94%b0%e6%8f%90%e4%ba%a4-cabometyx-%e7%9a%84\/","title":{"rendered":"\u533b\u7597\u4fdd\u5065\u7cbe\u9009\u2014\u2014CytoDyn\u63d0\u4ea4leronlimab\u7684\u8425\u9500\u7533\u8bf7\uff0c\u6b66\u7530\u63d0\u4ea4Cabometyx\u7684\u8865\u5145\u7533\u8bf7"},"content":{"rendered":"

CytoDyn<\/strong>\u63d0\u4ea4<\/strong>leronlimab<\/strong>\u8425\u9500\u7533\u8bf7<\/strong><\/h2>\n

\u82f1\u56fd\u836f\u54c1\u548c\u5065\u5eb7\u4ea7\u54c1\u7ba1\u7406\u5c40(MHRA)\u5df2\u6279\u51c6CytoDyn\uff08OTCQB\uff1aCYDY\uff09<\/a>\u63d0\u4ea4\u7684leronlimab\u7684\u751f\u7269\u5236\u5242\u8bb8\u53ef\u7533\u8bf7\uff08BLA\uff09\uff0c\u4f5c\u4e3a\u9488\u5bf9\u591a\u836f\u8010\u836fHIV\u60a3\u8005\u7684\u8054\u5408\u7597\u6cd5\u3002<\/p>\n

\u603b\u88c1\u517c\u9996\u5e2d\u6267\u884c\u5b98Nader Pourhassan\u535a\u58eb\u8bf4\uff1a\u201c\u6211\u4eec\u5bf9MHRA\u6279\u51c6BLA\u5907\u6848\u7684\u51b3\u5b9a\u611f\u5230\u975e\u5e38\u6ee1\u610f\uff0c\u6211\u4eec\u7684\u56e2\u961f\u6b63\u5728\u6572\u5b9a\u5176\u4f59\u7ec6\u8282\uff0c\u4ee5\u786e\u4fdd\u5c3d\u5feb\u5b8c\u6210\u5907\u6848\u3002\u6211\u4eec\u5e0c\u671b\u5728\u63d0\u51fa\u7533\u8bf7\u540e\u7684\u4e24\u5468\u5185\u6536\u5230\u63a5\u53d7\u901a\u77e5\u3002\u201d<\/p>\n

\u6b66\u7530\u63d0\u4ea4<\/strong>Cabometyx<\/strong>\u7684\u8865\u5145\u7533\u8bf7<\/strong><\/h2>\n

Exelixis\uff08NASDAQ\uff1aEXEL\uff09<\/a>\u7684\u4f19\u4f34\u6b66\u7530\u5236\u836f\uff08NYSE\uff1aTAK\uff09\u548c\u5927\u91ce\u5236\u836f\u5df2\u5728\u65e5\u672c\u63d0\u4ea4\u4e86\u8865\u5145\u7533\u8bf7\uff0c\u7528\u4e8e\u5c06CABOMETYX\u4e0eOPDIVO\uff08nivolumab\uff09\u7ed3\u5408\u7528\u4e8e\u5236\u9020\u548c\u9500\u552eCABOMETYX\uff0c\u7528\u4e8e\u6cbb\u7597\u4e0d\u53ef\u5207\u9664\u3001\u665a\u671f\u6216\u8f6c\u79fb\u6027\u60a3\u8005\u80be\u7ec6\u80de\u764c\uff08RCC\uff09\u3002<\/p>\n

Centene<\/strong>\u6bcf\u80a1\u6536\u76ca\u589e\u957f<\/strong><\/h2>\n

Centene\uff08NYSE\uff1aCNC\uff09<\/a>\uff1a\u7b2c\u4e09\u8d22\u5b63\u975eGAAP\u6bcf\u80a1\u6536\u76ca\u4e3a1.26\u7f8e\u5143\uff0c\u8f83\u4e0a\u5e74\u540c\u671f\u589e\u957f0.30\u7f8e\u5143; GAAP\u6bcf\u80a1\u6536\u76ca\u4e3a0.97\u7f8e\u5143\uff0c\u589e\u957f0.31\u7f8e\u5143\u3002<\/p>\n

\u6536\u5165$290.9\u4ebf\uff08\u540c\u6bd4\u589e\u957f53.3%\uff09\u3002<\/p>\n

\u80a1\u4ef7+ 0.17%\u3002<\/p>\n

\u9ed8\u514b\u5236\u836f\u6bcf\u80a1\u6536\u76ca\u589e\u957f<\/strong>0.31<\/strong>\u7f8e\u5143<\/strong><\/h2>\n

\u9ed8\u514b\u516c\u53f8(NYSE:MRK)<\/a>\uff1a\u7b2c\u4e09\u8d22\u5b63\u975eGAAP\u6bcf\u80a1\u6536\u76ca1.74\u7f8e\u5143\uff0c\u8f83\u4e0a\u5e74\u540c\u671f\u589e\u957f0.31\u7f8e\u5143; GAAP\u6bcf\u80a1\u6536\u76ca\u4e3a1.16\u7f8e\u5143\uff0c\u589e\u957f0.14\u7f8e\u5143\u3002<\/p>\n

\u6536\u5165$125.5\u4ebf\uff08\u540c\u6bd4\u589e\u957f1.2%\uff09\u3002<\/p>\n

\u8f89\u745e\u6bcf\u80a1\u6536\u76ca\u589e\u957f<\/strong>0.01<\/strong>\u7f8e\u5143<\/strong><\/h2>\n

\u8f89\u745e\u516c\u53f8(NYSE:PFE)<\/a>\uff1a\u7b2c\u4e09\u8d22\u5b63\u975eGAAP\u6bcf\u80a1\u6536\u76ca\u4e3a0.72\u7f8e\u5143\uff0c\u6bd4\u4e0a\u5e74\u540c\u671f\u589e\u957f0.01\u7f8e\u5143; GAAP\u6bcf\u80a1\u4e8f\u635f0.39\u7f8e\u5143\uff0c\u51cf\u5c110.18\u7f8e\u5143\u3002<\/p>\n

\u6536\u5165$121.3\u4ebf\uff08\u540c\u6bd4\u4e0b\u964d-4.3%\uff09\u3002<\/p>\n

\u80a1\u4ef7-0.84%\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"

CytoDyn\u63d0\u4ea4leronlimab\u8425\u9500\u7533\u8bf7 \u82f1\u56fd\u836f\u54c1\u548c\u5065\u5eb7\u4ea7\u54c1\u7ba1\u7406\u5c40(MHRA)\u5df2\u6279\u51c6CytoDyn\uff08OT […]<\/p>\n","protected":false},"author":9,"featured_media":355235,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[427],"tags":[820,513,747,925,459],"class_list":["post-355254","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market-news-zh-hans","tag-820","tag-513","tag-747","tag-925","tag-459","sectors-life-science-zh-hans","locations-china-zh-hans","locations-us-zh-hans","exchange-nasdaq-zh-hans","exchange-nyse-zh-hans"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/355254","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/comments?post=355254"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/355254\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media\/355235"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media?parent=355254"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/categories?post=355254"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/tags?post=355254"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}